
Caripriza 1.5mg Capsule
Marketer
Mesmer Pharmaceuticals
Salt Composition
Cariprazine (1.5mg)
Overview Caripriza 1.5mg Capsule
Aripazine 1.5mg capsules treat schizophrenia (a condition causing hallucinations, delusions, and impaired thought processes and behavior) and manic episodes. It's also indicated for bipolar disorder management. Aripazine 1.5mg capsules can be taken with or without food, but consistent daily timing ensures stable blood levels. Follow your physician's prescribed dosage and duration; if a dose is missed, take it immediately upon recollection. Abrupt cessation is unsafe and may exacerbate symptoms; consult your doctor before stopping treatment. Immediately discontinue use if neuroleptic malignant syndrome (NMS) occurs (symptoms include high fever, muscle stiffness, altered mental state, or convulsions). Common side effects include movement disorders (extrapyramidal symptoms, akathisia), indigestion, nausea, drowsiness, and agitation. Postural hypotension (sudden blood pressure drop upon standing) may initially occur; rise slowly from a seated or lying position. Dizziness and sleepiness are possible; avoid driving or tasks demanding concentration until the drug's effects are understood. Weight gain is a potential side effect; healthy diet and exercise can mitigate this. Increased diabetes risk exists; regular glucose monitoring is advisable. Report any unusual mood shifts, new or worsening depression, or suicidal ideation to your doctor during treatment.
Primary Ingredients of Caripriza 1.5mg Capsule
No text was provided to rewrite.
Uses of Caripriza 1.5mg Capsule
Psychotic disorders encompassing schizophrenia and manic episodes
Major Benefits of Caripriza 1.5mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Caripriza 1.5mg Capsules. These capsules can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Caripriza 1.5mg Capsule:
- Extrapyramidal symptoms
- Akathisia (inability to stay still)
- Dyspepsia
- Sleepiness
- Restlessness
How to use Caripriza 1.5mg Capsule:
Follow your doctor's instructions precisely regarding dosage and treatment length for Caripriza 1.5mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.
How Caripriza 1.5mg Capsule works:
For bipolar disorder and schizophrenia, the 1.5mg Caripriza capsule helps restore equilibrium to brain chemicals like dopamine and serotonin, thereby improving mood, cognition, and conduct.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Caripriza 1.5mg Capsules may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Caripriza 1.5mg capsules during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the risks. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Caripriza 1.5mg capsules while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Caripriza 1.5mg Capsules on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Caripriza 1.5mg capsules are considered safe and do not require a dosage modification.
LiverSAFE IF PRESCRIBED
Caripriza 1.5mg capsules can be safely administered to individuals with hepatic impairment. No alteration of the Caripriza 1.5mg capsule dosage is necessary.
What if you forget to take Caripriza 1.5mg Capsule :
Should you forget a Caripriza 1.5mg Capsule dose, take it immediately if possible. If your next dose is imminent, however, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Caripriza 1.5mg Capsule
| Label | Value |
|---|---|
| Chemical Type | Six-membered nitrogen-containing rings |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Behavioral Class | Nontypical Antipsychotics |
